The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies
- PMID: 31199036
- DOI: 10.1111/jon.12643
The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies
Abstract
Background and purpose: The cingulate island sign (CIS) on 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET); ie, the relative preservation of mid-posterior cingulate cortex metabolism, is a supportive biomarker in the diagnostic criteria for dementia with Lewy bodies (DLB). However, limited information is currently available on the diagnostic value of the CIS on FDG-PET or 123 I-iodoamphetamine single-photon emission computed tomography (IMP-SPECT) for differentiating between mild cognitive impairment (MCI) due to Alzheimer's disease (AD) (MCI-AD) and MCI due to DLB (MCI-DLB).
Methods: We examined the CIS ratio in 9 AD patients, 9 DLB patients, 8 patients with MCI-AD, and 9 patients with MCI-DLB using FDG-PET and IMP-SPECT. The CIS ratio was calculated using NEUROSTAT software.
Results: In the dementia groups, a receiver operating characteristic analysis of the CIS ratio showed significant accuracy for differentiating between AD and DLB on FDG-PET and IMP-SPECT. In the MCI groups, only the FDG-PET derived CIS ratio displayed significant accuracy for differentiating between AD and DLB.
Conclusions: The FDG-PET and IMP-SPECT derived CIS ratios are both useful for differentiating between AD and DLB. The FDG-PET derived CIS ratio is more valuable than the IMP-SPECT derived CIS ratio for differential diagnosis in patients with MCI. A larger study is needed to confirm these results.
Keywords: FDG-PET; IMP-SPECT; cingulate island sign; dementia with Lewy bodies; mild cognitive impairment.
© 2019 by the American Society of Neuroimaging.
Similar articles
-
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.Psychiatry Res Neuroimaging. 2016 Mar 30;249:105-12. doi: 10.1016/j.pscychresns.2015.12.007. Epub 2015 Dec 28. Psychiatry Res Neuroimaging. 2016. PMID: 26857415
-
The cingulate island sign in patients with dementia with Lewy bodies or Alzheimer's disease: A direct comparison between 18F-FDG PET and 123I-IMP SPECT.Neurosci Lett. 2018 Sep 14;683:168-173. doi: 10.1016/j.neulet.2018.07.040. Epub 2018 Jul 31. Neurosci Lett. 2018. Retraction in: Neurosci Lett. 2019 Jan 18;690:237. doi: 10.1016/j.neulet.2018.11.020. PMID: 30075285 Retracted.
-
The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies.J Nucl Med. 2009 Oct;50(10):1638-45. doi: 10.2967/jnumed.109.065870. Epub 2009 Sep 16. J Nucl Med. 2009. PMID: 19759102 Clinical Trial.
-
Clinical utility of FDG-PET for the clinical diagnosis in MCI.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1497-1508. doi: 10.1007/s00259-018-4039-7. Epub 2018 Apr 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29704037 Review.
-
Markers for the detection of Lewy body disease versus Alzheimer's disease in mild cognitive impairment: a systematic review and meta-analysis.Aging Clin Exp Res. 2024 Mar 7;36(1):60. doi: 10.1007/s40520-024-02704-y. Aging Clin Exp Res. 2024. PMID: 38451331 Free PMC article.
Cited by
-
Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling.J Neurol. 2021 Apr;268(4):1284-1294. doi: 10.1007/s00415-020-10271-1. Epub 2020 Oct 21. J Neurol. 2021. PMID: 33084940 Free PMC article.
-
Neuroanatomical and clinical correlates of prodromal dementia with Lewy bodies: a systematic literature review of neuroimaging findings.J Neurol. 2024 Dec 12;272(1):38. doi: 10.1007/s00415-024-12726-1. J Neurol. 2024. PMID: 39666108
-
Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease.Neural Regen Res. 2021 Jan;16(1):73-79. doi: 10.4103/1673-5374.286957. Neural Regen Res. 2021. PMID: 32788450 Free PMC article.
-
Clinical validity and reproducibility of a visual rating scale for cingulate island sign in a real-world memory clinic: An FDG-PET/MRI study.Eur J Neurol. 2025 Jan;32(1):e70015. doi: 10.1111/ene.70015. Eur J Neurol. 2025. PMID: 39723490 Free PMC article.
-
Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.J Neurol. 2022 Feb;269(2):639-653. doi: 10.1007/s00415-021-10402-2. Epub 2021 Jan 29. J Neurol. 2022. PMID: 33511432 Review.
References
-
- McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 2017;89:88-100.
-
- Chiba Y, Iseki E, Fujishiro H, et al. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: comparison between (18)F-FDG PET and (123)I-IMP SPECT. Psychiatry Res Neuroimaging 2016;249:105-12.
-
- Lim SM, Katsifis A, Villemagne VL, et al. The 18F-FDG PET cingulate Island sign and comparison to 123I-β-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 2009;50:1638-45.
-
- Graff-Radford J, Murray ME, Lowe VJ, et al. Dementia with Lewy bodies: basis of cingulate island sign. Neurology 2014;83:801-9.
-
- Iizuka T, Kameyama M. Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies. Ann Nucl Med 2016;30:421-9.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical